Replies to post #118893 on Biotech Values

[DewDiligence]

Amphastar’s modified complaint against the FDA has nothing new of consequence to investors, IMO. For those with time to burn who wish to read it anyhow, here it is:

Click here

Thanks to mouton for making this document available.